Services
Applications
- - - Disease Area
  - - Application Area
Technology
Resources
About
Menu Menu

Join Our Team
Contact

Next-Generation Biomarkers in Cancer Precision Medicine

Get your FREE white paper today!

Antibodies that target self-molecules called “autoantibodies” can serve as precise and reliable biomarkers in cancer.

Download this comprehensive white paper to:

Understand how cancer and cancer treatment can induce autoantibody production

Explore the critical role of autoantibodies in early cancer diagnosis and predicting patient outcomes

Discover how autoantibody profiling guides cancer drug development

"*" indicates required fields

First Name*

Last Name*

Title*

Email*

Organization*

Country*

Research Field(s)*

Autoimmune Disease

Dermatology

Immunology

Infectious Disease

Neurobiology

Oncology

Rare Disease

Others

Research Sector*

Currently conducting biomarker research?*

How did you hear about us? (Check all that apply)*

Internet Ads

Search Engine (e.g. Google)

Social Media

Webinar

Word of Mouth

Other

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.

I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

Comments

This field is for validation purposes and should be left unchanged.

Δ

Autoantibody Biomarkers in Cancer

Sengenics KREX^® technology measures antibody biomarkers with industry-leading precision

Reveal targetable antigens | Unveil targetable or exploitable antibodies | Uncover disease mechanisms | Identify disease subtypes

Services
Applications
Technology
Resources
About

Sengenics, a functional proteomics company, is committed to advancing precision medicine by empowering researchers with biologically relevant and actionable immunoproteomic insights across a broad spectrum of diseases. At the heart of its mission, Sengenics offers advanced, high-throughput tools using proprietary technology to precisely detect autoantibody biomarkers and protein interactions for basic, translational, and clinical research. Its robust tools have been leveraged by top pharmaceutical companies and leading research institutions to enhance disease understanding and streamline the biomarker pipeline.

© 2024 Sengenics Corporation LLC. All rights reserved. Sengenics Corporation LLC. Registered in Delaware, USA no. 5739583 | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D

Terms & Conditions | Terms of Use | Privacy Statement | Cookie Policy | Code of Conduct | Whistleblowing Policy | Sitemap

Design and development by RainCastle Communications.

"*" indicates required fields

Fill in the form to download the publication

First Name*

Last Name*

Email*

Organization*

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

Phone

This field is for validation purposes and should be left unchanged.

Δ

"*" indicates required fields

Watch the video

Name*

Email*

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

Email

This field is for validation purposes and should be left unchanged.

Δ

"*" indicates required fields

Watch the video

Name*

Email*

"*" Indicates required fields

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

Comments

This field is for validation purposes and should be left unchanged.

Δ

"*" indicates required fields

Autoantibody-Based Diagnostic Biomarkers: Technological Approaches to Discovery and Validation

Read the Review

Name*

Email*

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

Comments

This field is for validation purposes and should be left unchanged.

Δ

"*" indicates required fields

Watch the video

Name*

Email*

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

Email

This field is for validation purposes and should be left unchanged.

Δ